Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 1 Issue 9, September 1995

Editorial

Top of page ⤴

Letters to the Editor

Top of page ⤴

News

Top of page ⤴

Commentary

  • Three recent reports describe the first in vivo attempts at fetal gene therapy. The results underline the need for more intensive studies of the scientific and ethical implications of this new and perhaps more preventive approach to gene therapy.

    • Charles Coutelle
    • Anne-Marie Douar
    • Ursula Froster
    Commentary
  • Full analysis of two microbial genomes points towards complete catalogues of virulence and disease genes while tracking the course of evolution.

    • David Schlessinger
    Commentary
  • The current resurgence of interest in xenotransplantation will result in better definition of the mechanisms responsible for xenograft rejection and should facilitate appropriate therapeutic strategies to provide for long-term graft survival.

    • F.H. Bach
    • S.C. Robson
    • W.W. Hancock
    Commentary
Top of page ⤴

News & Views

  • Although many genes have been linked to inherited retinal disorders, it is difficult to explain how specific mutations can cause such a wide variety of phenotypes.

    • David S. Papermaster
    News & Views
  • As knowledge about the importance of the p53 protein grows, so do the number of potential options for successful treatment of cancer.

    • Jo Milner
    News & Views
  • The long search for a second HIV receptor, though not over, may be closer to a finish with new studies of CD26 (pages 919–926).

    • Angus Dalgleish
    News & Views
  • A recent paper suggests that supplementing the diet with large amounts of vitamin A may overcome some inherited blindness. But it also raises some serious questions.

    • Ted S. Acott
    • Richard G. Weleber
    News & Views
  • Many obstacles to successful gene therapy remain to be overcome. Now one of them may be less imposing (pages 890–893).

    • Christopher Wilson
    • Mark A. Kay
    News & Views
Top of page ⤴

Article

Top of page ⤴

Book Review

Top of page ⤴

On the Market

Top of page ⤴

Search

Quick links